Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CMND
CLEARMIND MEDICINE INC.
NASDAQ
$1.76
▼ DOWN 2.76% (-0.05)

KEY STATISTICS

Market Cap$2.61 M
52w High$524.00
52w Low$1.43
Dividend Yield—
Frequency—
P/E-0.07
Volume22.35K
Shares Out.1.49M

COMPANY

LEADERSHIP

Adi Zuloff-Shani
CHIEF EXECUTIVE
Adi Zuloff-Shani

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 15, 2022
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
4

SPLIT RECORD

DATETYPERATIO
2026-05-21Reverse1:10
2025-12-15Reverse1:40
2023-11-28Reverse1:30
2022-10-11Reverse1:30
2022-10-03Reverse1:30
2022-09-30Reverse1:30

PRICE

$1.76 ▼ DOWN 2.76% (−$0.05)
OVERLAYS
$1.72$1.76$1.80$1.849:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.76

About Clearmind Medicine Inc.

https://www.clearmindmedicine.com ↗

Clearmind Medicine Inc., a Vancouver-based pre-clinical pharma company, develops novel psychedelic treatments for mental health issues, alcohol use disorders, binge behaviors, and related conditions.

INDUSTRY

Biotechnology

A PRODUCT CLEARMIND MEDICINE INC. IS KNOWN FOR

CMND-100
CMND-100

CMND-100, Clearmind Medicine's lead proprietary, non-hallucinogenic oral drug candidate for Alcohol Use Disorder, is currently in Phase I/IIa trials assessing safety and efficacy.

COMPETITORS

COMPETITOR
ATAI COMPARE
CMPS COMPARE
GHRS COMPARE
HELP COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
PSIL
0.00% · 1.4K

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score3

INSIDER TRADES

★
10 PERCENT OWNER
HRT FINANCIAL LP
Sale · 22.1K shares
2026-06-16
★
10 PERCENT OWNER
HRT FINANCIAL LP
Sale · 3.2K shares
2026-06-15
★
10 PERCENT OWNER
HRT FINANCIAL LP
Sale · 2.1K shares
2026-06-12
★
10 PERCENT OWNER
HRT FINANCIAL LP
Sale · 225.2K shares
2026-06-11

SECTORS PEERS

PEERPRICE
KZIA$13.58COMPARE
XBIO$3.98COMPARE
CNSP$5.52COMPARE
SNGX$0.38COMPARE
SILO$2.54COMPARE
GRI$1.92COMPARE
JAGX$0.81COMPARE